GCM
DXCM icon

Graham Capital Management’s DexCom DXCM Stock Holding History

Graham Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,593
Closed -$238K – 1252
2025
Q4 		$238K Sell
3,593
-1,047
-23% -$67.7K 0.01% 962
2025
Q3 		$312K Buy
+4,640
New +$367K ﹤0.01% 841
2024
Q4 		– Sell
-36,031
Closed -$2.42M – 1290
2024
Q3 		$2.42M Buy
36,031
+31,336
+667% +$2.57M 0.04% 235
2024
Q2 		$532K Sell
4,695
-17,631
-79% -$2.23M 0.01% 567
2024
Q1 		$3.1M Buy
22,326
+16,418
+278% +$2.06M 0.06% 179
2023
Q4 		$733K Sell
5,908
-19,238
-77% -$1.97M 0.02% 474
2023
Q3 		$2.35M Buy
+25,146
New +$2.83M 0.06% 184
2023
Q2 		– Sell
-7,001
Closed -$813K – 1038
2023
Q1 		$813K Buy
7,001
+1,669
+31% +$187K 0.02% 588
2022
Q4 		$604K Buy
5,332
+1,513
+40% +$166K 0.02% 706
2022
Q3 		$307K Buy
+3,819
New +$323K 0.01% 899
2022
Q1 		– Sell
-2,072
Closed -$278K – 918
2021
Q4 		$278K Buy
+2,072
New +$298K 0.01% 353

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Graham Capital Management's DXCM Position: Q1 2026 in Review

Graham Capital Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,593 shares — an estimated $238K sold.

Graham Capital Management first reported a position in DXCM in Q4 2021 and held it in 11 quarters. The position peaked at $3.1M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Graham Capital Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 3,593 DexCom shares in Q1 2026, an estimated $238K.
  • Graham Capital Management first reported a position in DexCom in Q4 2021 and held it in 11 quarters.
  • Graham Capital Management's DexCom position peaked at $3.1M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.